Cite
MLA Citation
M Lelong et al.. “P207 COVID-19: a prevalence rate two times lower than that of the general population in French patients with Inflammatory Bowel Disease treated with intravenous biologic agents.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i265–i266. http://access.bl.uk/ark:/81055/vdc_100150514399.0x00001c